Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Incidence of the Presumptive B.1.427/B.1.429 Variant Among Healthcare Personnel at a Northern California Academic Medical Center

BACKGROUND: Although mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines report >90% efficacy, breakthrough infections occur. Little is known about their effectiveness against SARS-CoV-2 variants, including the highly prevalent B.1.427/B.1.429 variant. METHODS: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobson, Karen B, Pinsky, Benjamin A, Montez Rath, Maria E, Wang, Hannah, Miller, Jacob A, Skhiri, Mehdi, Shepard, John, Mathew, Roshni, Lee, Grace, Bohman, Bryan, Parsonnet, Julie, Holubar, Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344553/
https://www.ncbi.nlm.nih.gov/pubmed/34137815
http://dx.doi.org/10.1093/cid/ciab554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344553/
https://www.ncbi.nlm.nih.gov/pubmed/34137815
http://dx.doi.org/10.1093/cid/ciab554

Ejemplares similares